$2.28
-0.04-1.72%
At close: -
$2.31
0.031.32%
After Hours: Jan 16, 9:27 AM EDT
Comments
Loading...
Oramed Pharmaceuticals (NASDAQ:ORMP) Stock, Earnings Estimates, EPS, And Revenue
Oramed Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Mar 5
EPS Estimate
$-0.070
Quarterly Revenue Estimate
–
Annual Revenue
(as of Sep 30)
(as of Sep 30)
–
Analyze the earnings history of Oramed Pharmaceuticals using advanced sorting and filters.
Data brought to you by Benzinga APIs
Oramed Pharmaceuticals (ORMP) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2024-11-07 | $-0.48 | $-0.07 | -585.7 % |
| Q2 | 2024-08-16 | $0.22 | $0.01 | 2100.0 % |
| Q1 | 2024-05-09 | $0.04 | $0.02 | 100.0 % |
| Q4 | 2024-03-06 | $0.33 | $-0.12 | 375.0 % |
Oramed Pharmaceuticals (ORMP) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q2 | 2024-08-16 | $0 | $250.00K | -100.0 % |
| Q3 | 2023-11-09 | $0 | $700.00K | -100.0 % |
| Q2 | 2023-08-10 | $674.00K | $700.00K | -3.71 % |
| Q1 | 2023-05-11 | $666.00K | $750.00K | -11.2 % |
FAQ
When is Oramed Pharmaceuticals (NASDAQ:ORMP) reporting earnings?
Oramed Pharmaceuticals (ORMP) is scheduled to report earnings on March 5, 2025. The last reported earnings were for reported on November 7, 2024 for Q3.
What were the latest earnings per share (EPS) for Oramed Pharmaceuticals (NASDAQ:ORMP)?
The Actual EPS was $-0.48, which missed the estimate of $-0.07.
What were Oramed Pharmaceuticals’s (NASDAQ:ORMP) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.